Cointime

Luxendo

company

About

Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.

  • Heidelberg,Baden-Wurttemberg,Germany
  • 11 - 50

Highlights

Total Funding Amount
€14M
Funding Rounds
2
Investors
4
Employee Profiles
1

Details

Last Funding Type
Series A
Last Funding Money Raised
€8M
Industries
Bioinformatics,Biotechnology,Manufacturing
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
LUXENDO GmbH

Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniques of widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€14M
Luxendo has raised a total of €14M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2017 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 12, 2017 Series A €8M 3 EMBL Ventures
EMBLEM Technology Transfer
LSP BioVentures 		— Detail
Oct 14, 2015 Series A €6M 2 EMBL Ventures
Life Sciences Partners 		— Detail

Investors

Number of Lead Investors
Number of Investors
5
4
Luxendo is funded by 4 investors. EMBL Ventures and EMBLEM Technology Transfer are the most recent investors.
Investor Name Lead Investor Funding Round
EMBL Ventures Yes Series A
EMBLEM Technology Transfer Yes Series A
LSP BioVentures Yes Series A
Life Sciences Partners Yes Series A

Employee Profiles

Number of Employee Profiles
1
Luxendo has 1 current employee profiles, including Executive Joachim Rothe
Joachim Rothe
Executive
Cointime
เนื้อหา
บริษัท